nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—CYP1A2—Pazopanib—kidney cancer	0.0318	0.436	CbGbCtD
Phenylephrine—CYP1A2—Erlotinib—kidney cancer	0.0227	0.311	CbGbCtD
Phenylephrine—CYP1A2—Sorafenib—kidney cancer	0.0184	0.253	CbGbCtD
Phenylephrine—Edrophonium—ACHE—kidney cancer	0.00992	0.36	CrCbGaD
Phenylephrine—Isoprenaline—MAPK1—kidney cancer	0.00606	0.22	CrCbGaD
Phenylephrine—Edrophonium—BCHE—kidney cancer	0.00584	0.212	CrCbGaD
Phenylephrine—Terbutaline—BCHE—kidney cancer	0.00442	0.161	CrCbGaD
Phenylephrine—Nervous system disorder—Erlotinib—kidney cancer	0.0015	0.00189	CcSEcCtD
Phenylephrine—Skin disorder—Erlotinib—kidney cancer	0.00149	0.00187	CcSEcCtD
Phenylephrine—Loss of consciousness—Sorafenib—kidney cancer	0.00148	0.00187	CcSEcCtD
Phenylephrine—Cardiac disorder—Vincristine—kidney cancer	0.00146	0.00184	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Doxorubicin—kidney cancer	0.00146	0.00184	CcSEcCtD
Phenylephrine—Hypertension—Sorafenib—kidney cancer	0.00146	0.00183	CcSEcCtD
Phenylephrine—Lacrimation increased—Doxorubicin—kidney cancer	0.00143	0.0018	CcSEcCtD
Phenylephrine—Angiopathy—Vincristine—kidney cancer	0.00143	0.0018	CcSEcCtD
Phenylephrine—Paraesthesia—Vinblastine—kidney cancer	0.00143	0.0018	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.00143	0.0018	CcSEcCtD
Phenylephrine—Paraesthesia—Everolimus—kidney cancer	0.00142	0.00179	CcSEcCtD
Phenylephrine—Mediastinal disorder—Vincristine—kidney cancer	0.00142	0.00179	CcSEcCtD
Phenylephrine—Pruritus—Pazopanib—kidney cancer	0.00142	0.00179	CcSEcCtD
Phenylephrine—Dyspnoea—Everolimus—kidney cancer	0.00141	0.00178	CcSEcCtD
Phenylephrine—Dizziness—Temsirolimus—kidney cancer	0.00141	0.00178	CcSEcCtD
Phenylephrine—Hypertension—Sunitinib—kidney cancer	0.0014	0.00177	CcSEcCtD
Phenylephrine—Cardiac disorder—Gemcitabine—kidney cancer	0.00139	0.00175	CcSEcCtD
Phenylephrine—Chest pain—Sunitinib—kidney cancer	0.00138	0.00174	CcSEcCtD
Phenylephrine—Mental disorder—Vincristine—kidney cancer	0.00138	0.00174	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Paclitaxel—kidney cancer	0.00138	0.00173	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.00137	0.00173	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Everolimus—kidney cancer	0.00137	0.00172	CcSEcCtD
Phenylephrine—Myocardial infarction—Paclitaxel—kidney cancer	0.00137	0.00172	CcSEcCtD
Phenylephrine—Dyspnoea—Erlotinib—kidney cancer	0.00136	0.00172	CcSEcCtD
Phenylephrine—Pain—Vinblastine—kidney cancer	0.00136	0.00171	CcSEcCtD
Phenylephrine—Atrioventricular block—Doxorubicin—kidney cancer	0.00136	0.00171	CcSEcCtD
Phenylephrine—Angiopathy—Gemcitabine—kidney cancer	0.00136	0.00171	CcSEcCtD
Phenylephrine—Abdominal pain upper—Capecitabine—kidney cancer	0.00136	0.00171	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Capecitabine—kidney cancer	0.00136	0.00171	CcSEcCtD
Phenylephrine—Pain—Everolimus—kidney cancer	0.00136	0.00171	CcSEcCtD
Phenylephrine—Vomiting—Temsirolimus—kidney cancer	0.00136	0.00171	CcSEcCtD
Phenylephrine—Shock—Sorafenib—kidney cancer	0.00135	0.00171	CcSEcCtD
Phenylephrine—Immune system disorder—Gemcitabine—kidney cancer	0.00135	0.0017	CcSEcCtD
Phenylephrine—Nervous system disorder—Sorafenib—kidney cancer	0.00135	0.0017	CcSEcCtD
Phenylephrine—Mediastinal disorder—Gemcitabine—kidney cancer	0.00135	0.0017	CcSEcCtD
Phenylephrine—Rash—Temsirolimus—kidney cancer	0.00134	0.00169	CcSEcCtD
Phenylephrine—Dermatitis—Temsirolimus—kidney cancer	0.00134	0.00169	CcSEcCtD
Phenylephrine—Skin disorder—Sorafenib—kidney cancer	0.00134	0.00168	CcSEcCtD
Phenylephrine—Arrhythmia—Gemcitabine—kidney cancer	0.00134	0.00168	CcSEcCtD
Phenylephrine—Headache—Temsirolimus—kidney cancer	0.00134	0.00168	CcSEcCtD
Phenylephrine—Neck pain—Doxorubicin—kidney cancer	0.00134	0.00168	CcSEcCtD
Phenylephrine—Dizziness—Pazopanib—kidney cancer	0.00133	0.00167	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00132	0.00166	CcSEcCtD
Phenylephrine—Pain—Erlotinib—kidney cancer	0.00131	0.00165	CcSEcCtD
Phenylephrine—Isoprenaline—CYP1A1—kidney cancer	0.0013	0.0473	CrCbGaD
Phenylephrine—Shock—Sunitinib—kidney cancer	0.0013	0.00164	CcSEcCtD
Phenylephrine—Nervous system disorder—Sunitinib—kidney cancer	0.0013	0.00164	CcSEcCtD
Phenylephrine—Skin disorder—Sunitinib—kidney cancer	0.00129	0.00162	CcSEcCtD
Phenylephrine—Vomiting—Pazopanib—kidney cancer	0.00128	0.00161	CcSEcCtD
Phenylephrine—Bradycardia—Paclitaxel—kidney cancer	0.00127	0.00161	CcSEcCtD
Phenylephrine—Rash—Pazopanib—kidney cancer	0.00127	0.0016	CcSEcCtD
Phenylephrine—Nausea—Temsirolimus—kidney cancer	0.00127	0.0016	CcSEcCtD
Phenylephrine—Dermatitis—Pazopanib—kidney cancer	0.00127	0.00159	CcSEcCtD
Phenylephrine—Agitation—Vincristine—kidney cancer	0.00126	0.00159	CcSEcCtD
Phenylephrine—Skin exfoliation—Doxorubicin—kidney cancer	0.00126	0.00159	CcSEcCtD
Phenylephrine—Headache—Pazopanib—kidney cancer	0.00126	0.00158	CcSEcCtD
Phenylephrine—Sweating increased—Capecitabine—kidney cancer	0.00125	0.00158	CcSEcCtD
Phenylephrine—Dyspnoea—Sorafenib—kidney cancer	0.00123	0.00155	CcSEcCtD
Phenylephrine—Visual impairment—Paclitaxel—kidney cancer	0.00121	0.00152	CcSEcCtD
Phenylephrine—Nausea—Pazopanib—kidney cancer	0.00119	0.0015	CcSEcCtD
Phenylephrine—Paraesthesia—Sunitinib—kidney cancer	0.00119	0.0015	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00119	0.0015	CcSEcCtD
Phenylephrine—Hypertension—Vincristine—kidney cancer	0.00119	0.00149	CcSEcCtD
Phenylephrine—Dyspnoea—Sunitinib—kidney cancer	0.00118	0.00149	CcSEcCtD
Phenylephrine—Pain—Sorafenib—kidney cancer	0.00118	0.00148	CcSEcCtD
Phenylephrine—Pulmonary oedema—Doxorubicin—kidney cancer	0.00117	0.00148	CcSEcCtD
Phenylephrine—Hypersensitivity—Vinblastine—kidney cancer	0.00117	0.00148	CcSEcCtD
Phenylephrine—Hypersensitivity—Everolimus—kidney cancer	0.00117	0.00147	CcSEcCtD
Phenylephrine—Cardiac disorder—Paclitaxel—kidney cancer	0.00116	0.00146	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00114	0.00144	CcSEcCtD
Phenylephrine—Angiopathy—Paclitaxel—kidney cancer	0.00114	0.00143	CcSEcCtD
Phenylephrine—Pain—Sunitinib—kidney cancer	0.00113	0.00143	CcSEcCtD
Phenylephrine—Immune system disorder—Paclitaxel—kidney cancer	0.00113	0.00143	CcSEcCtD
Phenylephrine—Mediastinal disorder—Paclitaxel—kidney cancer	0.00113	0.00142	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Capecitabine—kidney cancer	0.00113	0.00142	CcSEcCtD
Phenylephrine—Hypertension—Gemcitabine—kidney cancer	0.00112	0.00142	CcSEcCtD
Phenylephrine—Myocardial infarction—Capecitabine—kidney cancer	0.00112	0.00141	CcSEcCtD
Phenylephrine—Pruritus—Everolimus—kidney cancer	0.00112	0.00141	CcSEcCtD
Phenylephrine—Arrhythmia—Paclitaxel—kidney cancer	0.00112	0.00141	CcSEcCtD
Phenylephrine—Chest pain—Gemcitabine—kidney cancer	0.00111	0.0014	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.0011	0.00139	CcSEcCtD
Phenylephrine—Nervous system disorder—Vincristine—kidney cancer	0.0011	0.00138	CcSEcCtD
Phenylephrine—Mental disorder—Paclitaxel—kidney cancer	0.0011	0.00138	CcSEcCtD
Phenylephrine—Urticaria—Sorafenib—kidney cancer	0.00109	0.00138	CcSEcCtD
Phenylephrine—Hyperhidrosis—Vincristine—kidney cancer	0.00108	0.00136	CcSEcCtD
Phenylephrine—Pruritus—Erlotinib—kidney cancer	0.00108	0.00136	CcSEcCtD
Phenylephrine—Pain—Dactinomycin—kidney cancer	0.00107	0.00135	CcSEcCtD
Phenylephrine—Tension—Paclitaxel—kidney cancer	0.00107	0.00135	CcSEcCtD
Phenylephrine—Dysgeusia—Paclitaxel—kidney cancer	0.00107	0.00134	CcSEcCtD
Phenylephrine—Eye pain—Doxorubicin—kidney cancer	0.00106	0.00134	CcSEcCtD
Phenylephrine—Nervousness—Paclitaxel—kidney cancer	0.00106	0.00133	CcSEcCtD
Phenylephrine—Dizziness—Vinblastine—kidney cancer	0.00105	0.00133	CcSEcCtD
Phenylephrine—Dizziness—Everolimus—kidney cancer	0.00105	0.00132	CcSEcCtD
Phenylephrine—Bradycardia—Capecitabine—kidney cancer	0.00105	0.00132	CcSEcCtD
Phenylephrine—Nervous system disorder—Gemcitabine—kidney cancer	0.00104	0.00131	CcSEcCtD
Phenylephrine—Skin disorder—Gemcitabine—kidney cancer	0.00103	0.0013	CcSEcCtD
Phenylephrine—Vision blurred—Paclitaxel—kidney cancer	0.00103	0.00129	CcSEcCtD
Phenylephrine—Hyperhidrosis—Gemcitabine—kidney cancer	0.00103	0.00129	CcSEcCtD
Phenylephrine—Tremor—Paclitaxel—kidney cancer	0.00102	0.00129	CcSEcCtD
Phenylephrine—Hypersensitivity—Sorafenib—kidney cancer	0.00101	0.00128	CcSEcCtD
Phenylephrine—Vomiting—Vinblastine—kidney cancer	0.00101	0.00128	CcSEcCtD
Phenylephrine—Dizziness—Erlotinib—kidney cancer	0.00101	0.00127	CcSEcCtD
Phenylephrine—Vomiting—Everolimus—kidney cancer	0.00101	0.00127	CcSEcCtD
Phenylephrine—Paraesthesia—Vincristine—kidney cancer	0.00101	0.00127	CcSEcCtD
Phenylephrine—Agitation—Paclitaxel—kidney cancer	0.001	0.00126	CcSEcCtD
Phenylephrine—Rash—Everolimus—kidney cancer	0.001	0.00126	CcSEcCtD
Phenylephrine—Dermatitis—Everolimus—kidney cancer	0.000999	0.00126	CcSEcCtD
Phenylephrine—Headache—Vinblastine—kidney cancer	0.000997	0.00126	CcSEcCtD
Phenylephrine—Headache—Everolimus—kidney cancer	0.000993	0.00125	CcSEcCtD
Phenylephrine—Visual impairment—Capecitabine—kidney cancer	0.00099	0.00125	CcSEcCtD
Phenylephrine—Syncope—Paclitaxel—kidney cancer	0.000978	0.00123	CcSEcCtD
Phenylephrine—Hypersensitivity—Sunitinib—kidney cancer	0.000976	0.00123	CcSEcCtD
Phenylephrine—Pruritus—Sorafenib—kidney cancer	0.000974	0.00123	CcSEcCtD
Phenylephrine—Vomiting—Erlotinib—kidney cancer	0.000973	0.00123	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000967	0.00122	CcSEcCtD
Phenylephrine—Rash—Erlotinib—kidney cancer	0.000965	0.00122	CcSEcCtD
Phenylephrine—Dermatitis—Erlotinib—kidney cancer	0.000964	0.00121	CcSEcCtD
Phenylephrine—Palpitations—Paclitaxel—kidney cancer	0.000963	0.00121	CcSEcCtD
Phenylephrine—Headache—Erlotinib—kidney cancer	0.000958	0.00121	CcSEcCtD
Phenylephrine—Loss of consciousness—Paclitaxel—kidney cancer	0.000958	0.00121	CcSEcCtD
Phenylephrine—Pain—Vincristine—kidney cancer	0.000958	0.00121	CcSEcCtD
Phenylephrine—Paraesthesia—Gemcitabine—kidney cancer	0.000954	0.0012	CcSEcCtD
Phenylephrine—Cardiac disorder—Capecitabine—kidney cancer	0.000954	0.0012	CcSEcCtD
Phenylephrine—Dyspnoea—Gemcitabine—kidney cancer	0.000947	0.00119	CcSEcCtD
Phenylephrine—Nausea—Vinblastine—kidney cancer	0.000945	0.00119	CcSEcCtD
Phenylephrine—Nausea—Everolimus—kidney cancer	0.000942	0.00119	CcSEcCtD
Phenylephrine—Hypertension—Paclitaxel—kidney cancer	0.000941	0.00119	CcSEcCtD
Phenylephrine—Pruritus—Sunitinib—kidney cancer	0.000937	0.00118	CcSEcCtD
Phenylephrine—Angiopathy—Capecitabine—kidney cancer	0.000932	0.00117	CcSEcCtD
Phenylephrine—Immune system disorder—Capecitabine—kidney cancer	0.000928	0.00117	CcSEcCtD
Phenylephrine—Chest pain—Paclitaxel—kidney cancer	0.000928	0.00117	CcSEcCtD
Phenylephrine—Mediastinal disorder—Capecitabine—kidney cancer	0.000926	0.00117	CcSEcCtD
Phenylephrine—Hypersensitivity—Dactinomycin—kidney cancer	0.000924	0.00116	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000922	0.00116	CcSEcCtD
Phenylephrine—Arrhythmia—Capecitabine—kidney cancer	0.000918	0.00116	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000917	0.00116	CcSEcCtD
Phenylephrine—Dizziness—Sorafenib—kidney cancer	0.00091	0.00115	CcSEcCtD
Phenylephrine—Pain—Gemcitabine—kidney cancer	0.000909	0.00114	CcSEcCtD
Phenylephrine—Nausea—Erlotinib—kidney cancer	0.000909	0.00114	CcSEcCtD
Phenylephrine—Mental disorder—Capecitabine—kidney cancer	0.0009	0.00113	CcSEcCtD
Phenylephrine—Dysgeusia—Capecitabine—kidney cancer	0.000876	0.0011	CcSEcCtD
Phenylephrine—Dizziness—Sunitinib—kidney cancer	0.000876	0.0011	CcSEcCtD
Phenylephrine—Shock—Paclitaxel—kidney cancer	0.000875	0.0011	CcSEcCtD
Phenylephrine—Vomiting—Sorafenib—kidney cancer	0.000875	0.0011	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000875	0.0011	CcSEcCtD
Phenylephrine—Abdominal pain upper—Doxorubicin—kidney cancer	0.000875	0.0011	CcSEcCtD
Phenylephrine—Nervous system disorder—Paclitaxel—kidney cancer	0.000873	0.0011	CcSEcCtD
Phenylephrine—Tachycardia—Paclitaxel—kidney cancer	0.000868	0.00109	CcSEcCtD
Phenylephrine—Rash—Sorafenib—kidney cancer	0.000868	0.00109	CcSEcCtD
Phenylephrine—Dermatitis—Sorafenib—kidney cancer	0.000867	0.00109	CcSEcCtD
Phenylephrine—Skin disorder—Paclitaxel—kidney cancer	0.000864	0.00109	CcSEcCtD
Phenylephrine—Headache—Sorafenib—kidney cancer	0.000862	0.00109	CcSEcCtD
Phenylephrine—Hyperhidrosis—Paclitaxel—kidney cancer	0.00086	0.00108	CcSEcCtD
Phenylephrine—Vision blurred—Capecitabine—kidney cancer	0.000843	0.00106	CcSEcCtD
Phenylephrine—Vomiting—Sunitinib—kidney cancer	0.000842	0.00106	CcSEcCtD
Phenylephrine—Tremor—Capecitabine—kidney cancer	0.000838	0.00106	CcSEcCtD
Phenylephrine—Rash—Sunitinib—kidney cancer	0.000835	0.00105	CcSEcCtD
Phenylephrine—Dermatitis—Sunitinib—kidney cancer	0.000834	0.00105	CcSEcCtD
Phenylephrine—Headache—Sunitinib—kidney cancer	0.00083	0.00105	CcSEcCtD
Phenylephrine—Hypersensitivity—Vincristine—kidney cancer	0.000825	0.00104	CcSEcCtD
Phenylephrine—Nausea—Sorafenib—kidney cancer	0.000818	0.00103	CcSEcCtD
Phenylephrine—Syncope—Capecitabine—kidney cancer	0.000802	0.00101	CcSEcCtD
Phenylephrine—Paraesthesia—Paclitaxel—kidney cancer	0.000799	0.00101	CcSEcCtD
Phenylephrine—Vomiting—Dactinomycin—kidney cancer	0.000797	0.001	CcSEcCtD
Phenylephrine—Dyspnoea—Paclitaxel—kidney cancer	0.000793	0.000999	CcSEcCtD
Phenylephrine—Palpitations—Capecitabine—kidney cancer	0.000791	0.000996	CcSEcCtD
Phenylephrine—Rash—Dactinomycin—kidney cancer	0.000791	0.000996	CcSEcCtD
Phenylephrine—Nausea—Sunitinib—kidney cancer	0.000787	0.000991	CcSEcCtD
Phenylephrine—Loss of consciousness—Capecitabine—kidney cancer	0.000786	0.000991	CcSEcCtD
Phenylephrine—Hypertension—Capecitabine—kidney cancer	0.000772	0.000973	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000768	0.000968	CcSEcCtD
Phenylephrine—Chest pain—Capecitabine—kidney cancer	0.000762	0.00096	CcSEcCtD
Phenylephrine—Pain—Paclitaxel—kidney cancer	0.000761	0.000959	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000756	0.000953	CcSEcCtD
Phenylephrine—Pruritus—Gemcitabine—kidney cancer	0.000752	0.000947	CcSEcCtD
Phenylephrine—Nausea—Dactinomycin—kidney cancer	0.000745	0.000938	CcSEcCtD
Phenylephrine—Dizziness—Vincristine—kidney cancer	0.000741	0.000933	CcSEcCtD
Phenylephrine—Shock—Capecitabine—kidney cancer	0.000718	0.000905	CcSEcCtD
Phenylephrine—Nervous system disorder—Capecitabine—kidney cancer	0.000716	0.000902	CcSEcCtD
Phenylephrine—Tachycardia—Capecitabine—kidney cancer	0.000713	0.000898	CcSEcCtD
Phenylephrine—Vomiting—Vincristine—kidney cancer	0.000712	0.000897	CcSEcCtD
Phenylephrine—Skin disorder—Capecitabine—kidney cancer	0.000709	0.000893	CcSEcCtD
Phenylephrine—Urticaria—Paclitaxel—kidney cancer	0.000707	0.00089	CcSEcCtD
Phenylephrine—Rash—Vincristine—kidney cancer	0.000706	0.00089	CcSEcCtD
Phenylephrine—Hyperhidrosis—Capecitabine—kidney cancer	0.000706	0.000889	CcSEcCtD
Phenylephrine—Dermatitis—Vincristine—kidney cancer	0.000706	0.000889	CcSEcCtD
Phenylephrine—Headache—Vincristine—kidney cancer	0.000702	0.000884	CcSEcCtD
Phenylephrine—Vomiting—Gemcitabine—kidney cancer	0.000676	0.000851	CcSEcCtD
Phenylephrine—Bradycardia—Doxorubicin—kidney cancer	0.000674	0.00085	CcSEcCtD
Phenylephrine—Rash—Gemcitabine—kidney cancer	0.00067	0.000844	CcSEcCtD
Phenylephrine—Dermatitis—Gemcitabine—kidney cancer	0.000669	0.000843	CcSEcCtD
Phenylephrine—Headache—Gemcitabine—kidney cancer	0.000666	0.000839	CcSEcCtD
Phenylephrine—Nausea—Vincristine—kidney cancer	0.000665	0.000838	CcSEcCtD
Phenylephrine—Paraesthesia—Capecitabine—kidney cancer	0.000656	0.000826	CcSEcCtD
Phenylephrine—Hypersensitivity—Paclitaxel—kidney cancer	0.000656	0.000826	CcSEcCtD
Phenylephrine—Dyspnoea—Capecitabine—kidney cancer	0.000651	0.00082	CcSEcCtD
Phenylephrine—Visual impairment—Doxorubicin—kidney cancer	0.000638	0.000804	CcSEcCtD
Phenylephrine—Nausea—Gemcitabine—kidney cancer	0.000631	0.000795	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00063	0.000794	CcSEcCtD
Phenylephrine—Pruritus—Paclitaxel—kidney cancer	0.000629	0.000793	CcSEcCtD
Phenylephrine—Pain—Capecitabine—kidney cancer	0.000624	0.000787	CcSEcCtD
Phenylephrine—Cardiac disorder—Doxorubicin—kidney cancer	0.000615	0.000775	CcSEcCtD
Phenylephrine—Angiopathy—Doxorubicin—kidney cancer	0.000601	0.000757	CcSEcCtD
Phenylephrine—Immune system disorder—Doxorubicin—kidney cancer	0.000598	0.000754	CcSEcCtD
Phenylephrine—Mediastinal disorder—Doxorubicin—kidney cancer	0.000597	0.000752	CcSEcCtD
Phenylephrine—Arrhythmia—Doxorubicin—kidney cancer	0.000592	0.000746	CcSEcCtD
Phenylephrine—Dizziness—Paclitaxel—kidney cancer	0.000588	0.000741	CcSEcCtD
Phenylephrine—Mental disorder—Doxorubicin—kidney cancer	0.00058	0.000731	CcSEcCtD
Phenylephrine—Urticaria—Capecitabine—kidney cancer	0.00058	0.000731	CcSEcCtD
Phenylephrine—Tension—Doxorubicin—kidney cancer	0.000566	0.000713	CcSEcCtD
Phenylephrine—Vomiting—Paclitaxel—kidney cancer	0.000566	0.000713	CcSEcCtD
Phenylephrine—Dysgeusia—Doxorubicin—kidney cancer	0.000565	0.000711	CcSEcCtD
Phenylephrine—Rash—Paclitaxel—kidney cancer	0.000561	0.000707	CcSEcCtD
Phenylephrine—Dermatitis—Paclitaxel—kidney cancer	0.00056	0.000706	CcSEcCtD
Phenylephrine—Nervousness—Doxorubicin—kidney cancer	0.00056	0.000706	CcSEcCtD
Phenylephrine—Headache—Paclitaxel—kidney cancer	0.000557	0.000702	CcSEcCtD
Phenylephrine—Vision blurred—Doxorubicin—kidney cancer	0.000543	0.000685	CcSEcCtD
Phenylephrine—Hypersensitivity—Capecitabine—kidney cancer	0.000538	0.000678	CcSEcCtD
Phenylephrine—Agitation—Doxorubicin—kidney cancer	0.00053	0.000668	CcSEcCtD
Phenylephrine—Nausea—Paclitaxel—kidney cancer	0.000528	0.000666	CcSEcCtD
Phenylephrine—Syncope—Doxorubicin—kidney cancer	0.000517	0.000652	CcSEcCtD
Phenylephrine—Pruritus—Capecitabine—kidney cancer	0.000517	0.000651	CcSEcCtD
Phenylephrine—Palpitations—Doxorubicin—kidney cancer	0.00051	0.000642	CcSEcCtD
Phenylephrine—Loss of consciousness—Doxorubicin—kidney cancer	0.000507	0.000639	CcSEcCtD
Phenylephrine—Hypertension—Doxorubicin—kidney cancer	0.000498	0.000627	CcSEcCtD
Phenylephrine—Chest pain—Doxorubicin—kidney cancer	0.000491	0.000619	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000488	0.000614	CcSEcCtD
Phenylephrine—Dizziness—Capecitabine—kidney cancer	0.000483	0.000608	CcSEcCtD
Phenylephrine—Vomiting—Capecitabine—kidney cancer	0.000464	0.000585	CcSEcCtD
Phenylephrine—Shock—Doxorubicin—kidney cancer	0.000463	0.000583	CcSEcCtD
Phenylephrine—Nervous system disorder—Doxorubicin—kidney cancer	0.000462	0.000581	CcSEcCtD
Phenylephrine—Rash—Capecitabine—kidney cancer	0.00046	0.00058	CcSEcCtD
Phenylephrine—Dermatitis—Capecitabine—kidney cancer	0.00046	0.000579	CcSEcCtD
Phenylephrine—Tachycardia—Doxorubicin—kidney cancer	0.000459	0.000579	CcSEcCtD
Phenylephrine—Headache—Capecitabine—kidney cancer	0.000457	0.000576	CcSEcCtD
Phenylephrine—Skin disorder—Doxorubicin—kidney cancer	0.000457	0.000576	CcSEcCtD
Phenylephrine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000455	0.000573	CcSEcCtD
Phenylephrine—Nausea—Capecitabine—kidney cancer	0.000434	0.000546	CcSEcCtD
Phenylephrine—Paraesthesia—Doxorubicin—kidney cancer	0.000423	0.000532	CcSEcCtD
Phenylephrine—Dyspnoea—Doxorubicin—kidney cancer	0.00042	0.000529	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000406	0.000512	CcSEcCtD
Phenylephrine—Pain—Doxorubicin—kidney cancer	0.000402	0.000507	CcSEcCtD
Phenylephrine—Urticaria—Doxorubicin—kidney cancer	0.000374	0.000471	CcSEcCtD
Phenylephrine—Hypersensitivity—Doxorubicin—kidney cancer	0.000347	0.000437	CcSEcCtD
Phenylephrine—Pruritus—Doxorubicin—kidney cancer	0.000333	0.00042	CcSEcCtD
Phenylephrine—Dizziness—Doxorubicin—kidney cancer	0.000311	0.000392	CcSEcCtD
Phenylephrine—Vomiting—Doxorubicin—kidney cancer	0.000299	0.000377	CcSEcCtD
Phenylephrine—Rash—Doxorubicin—kidney cancer	0.000297	0.000374	CcSEcCtD
Phenylephrine—Dermatitis—Doxorubicin—kidney cancer	0.000296	0.000374	CcSEcCtD
Phenylephrine—Headache—Doxorubicin—kidney cancer	0.000295	0.000371	CcSEcCtD
Phenylephrine—Nausea—Doxorubicin—kidney cancer	0.00028	0.000352	CcSEcCtD
Phenylephrine—ADRA1D—Signaling Pathways—SFRP2—kidney cancer	0.000109	0.00103	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	0.000109	0.00103	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	0.000107	0.00101	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.000107	0.00101	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GPC3—kidney cancer	0.000106	0.00101	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CER1—kidney cancer	0.000106	0.00101	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—ANXA1—kidney cancer	0.000106	0.001	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—ITPR2—kidney cancer	0.000105	0.000993	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—ITPR2—kidney cancer	0.000103	0.000971	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.000102	0.00096	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—POMC—kidney cancer	0.000101	0.000957	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CRABP1—kidney cancer	9.86e-05	0.000932	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—PIK3CA—kidney cancer	9.85e-05	0.000931	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	9.8e-05	0.000926	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—ANXA1—kidney cancer	9.69e-05	0.000916	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	9.59e-05	0.000906	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ACY1—kidney cancer	9.57e-05	0.000905	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CER1—kidney cancer	9.46e-05	0.000894	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GPC3—kidney cancer	9.46e-05	0.000894	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—ITPR2—kidney cancer	9.33e-05	0.000882	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ITPR2—kidney cancer	9.17e-05	0.000866	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SFRP2—kidney cancer	9.05e-05	0.000856	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	8.86e-05	0.000837	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	8.81e-05	0.000833	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—ANXA1—kidney cancer	8.8e-05	0.000832	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKAP13—kidney cancer	8.79e-05	0.000831	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CASP2—kidney cancer	8.79e-05	0.000831	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—ANXA1—kidney cancer	8.61e-05	0.000814	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—MAPK1—kidney cancer	8.45e-05	0.000799	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	8.43e-05	0.000796	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—POMC—kidney cancer	8.4e-05	0.000794	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTT1—kidney cancer	8.36e-05	0.00079	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ACHE—kidney cancer	8.36e-05	0.00079	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—PIK3CA—kidney cancer	8.18e-05	0.000773	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	8.16e-05	0.000772	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PDHB—kidney cancer	8.14e-05	0.000769	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—POMC—kidney cancer	8.12e-05	0.000767	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GRB7—kidney cancer	8.04e-05	0.00076	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SFRP2—kidney cancer	8.04e-05	0.00076	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	7.96e-05	0.000752	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—SCARB1—kidney cancer	7.91e-05	0.000748	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	7.87e-05	0.000743	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTGS1—kidney cancer	7.83e-05	0.00074	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—ANXA1—kidney cancer	7.82e-05	0.000739	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PSMD7—kidney cancer	7.68e-05	0.000726	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CCBL1—kidney cancer	7.65e-05	0.000723	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	7.49e-05	0.000707	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ITPR2—kidney cancer	7.48e-05	0.000706	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—POMC—kidney cancer	7.46e-05	0.000705	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	7.31e-05	0.000691	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CASP2—kidney cancer	7.3e-05	0.00069	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKAP13—kidney cancer	7.3e-05	0.00069	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—BCHE—kidney cancer	7.28e-05	0.000688	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—PIK3CA—kidney cancer	7.26e-05	0.000686	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—SLC5A5—kidney cancer	7.19e-05	0.00068	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	7.07e-05	0.000668	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—SLC2A1—kidney cancer	6.95e-05	0.000656	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	6.92e-05	0.000654	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CTNNA1—kidney cancer	6.78e-05	0.00064	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EIF4EBP1—kidney cancer	6.74e-05	0.000637	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HSPB1—kidney cancer	6.74e-05	0.000637	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GRB7—kidney cancer	6.67e-05	0.000631	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GLIPR1—kidney cancer	6.64e-05	0.000627	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPAT—kidney cancer	6.64e-05	0.000627	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.55e-05	0.000619	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	6.5e-05	0.000614	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.49e-05	0.000613	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKAP13—kidney cancer	6.48e-05	0.000613	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CASP2—kidney cancer	6.48e-05	0.000613	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TSC1—kidney cancer	6.26e-05	0.000592	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PSMD7—kidney cancer	6.26e-05	0.000592	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ANXA1—kidney cancer	6.26e-05	0.000592	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ITPR2—kidney cancer	6.2e-05	0.000586	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APRT—kidney cancer	6.17e-05	0.000583	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—FH—kidney cancer	6.17e-05	0.000583	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FLT1—kidney cancer	6.07e-05	0.000573	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.03e-05	0.00057	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GRB7—kidney cancer	5.93e-05	0.00056	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GPC3—kidney cancer	5.8e-05	0.000548	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTP1—kidney cancer	5.79e-05	0.000548	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—POMC—kidney cancer	5.72e-05	0.000541	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CA2—kidney cancer	5.64e-05	0.000533	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CTNNA1—kidney cancer	5.62e-05	0.000532	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—JUNB—kidney cancer	5.62e-05	0.000531	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PAK1—kidney cancer	5.62e-05	0.000531	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EIF4EBP1—kidney cancer	5.59e-05	0.000529	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HSPB1—kidney cancer	5.59e-05	0.000529	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ITPR2—kidney cancer	5.51e-05	0.000521	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALAD—kidney cancer	5.5e-05	0.00052	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ABCB1—kidney cancer	5.48e-05	0.000518	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ST3GAL2—kidney cancer	5.37e-05	0.000507	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTM1—kidney cancer	5.32e-05	0.000503	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALDH1A1—kidney cancer	5.25e-05	0.000496	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TSC1—kidney cancer	5.2e-05	0.000491	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ANXA1—kidney cancer	5.2e-05	0.000491	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PSMD7—kidney cancer	5.2e-05	0.000491	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—POMC—kidney cancer	5.2e-05	0.000491	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP1A1—kidney cancer	5.05e-05	0.000477	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FLT1—kidney cancer	5.04e-05	0.000476	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC5A3—kidney cancer	5.03e-05	0.000475	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PGK1—kidney cancer	5.03e-05	0.000475	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CTNNA1—kidney cancer	5e-05	0.000472	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EIF4EBP1—kidney cancer	4.97e-05	0.000469	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HSPB1—kidney cancer	4.97e-05	0.000469	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—LDHB—kidney cancer	4.93e-05	0.000466	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—POMC—kidney cancer	4.75e-05	0.000449	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PAK1—kidney cancer	4.67e-05	0.000441	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—JUNB—kidney cancer	4.67e-05	0.000441	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PSMD7—kidney cancer	4.62e-05	0.000436	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ANXA1—kidney cancer	4.62e-05	0.000436	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TSC1—kidney cancer	4.62e-05	0.000436	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF2—kidney cancer	4.6e-05	0.000435	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CDKN2B—kidney cancer	4.58e-05	0.000433	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FLT1—kidney cancer	4.47e-05	0.000423	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF1R—kidney cancer	4.45e-05	0.00042	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—POMC—kidney cancer	4.31e-05	0.000408	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—RAF1—kidney cancer	4.28e-05	0.000405	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CA9—kidney cancer	4.28e-05	0.000404	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—IL2—kidney cancer	4.23e-05	0.0004	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—POMC—kidney cancer	4.22e-05	0.000399	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.18e-05	0.000395	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PAK1—kidney cancer	4.15e-05	0.000392	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—JUNB—kidney cancer	4.15e-05	0.000392	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL2—kidney cancer	3.84e-05	0.000363	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—POMC—kidney cancer	3.83e-05	0.000362	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF2—kidney cancer	3.82e-05	0.000361	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN2B—kidney cancer	3.8e-05	0.000359	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—POMC—kidney cancer	3.76e-05	0.000356	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF1R—kidney cancer	3.69e-05	0.000349	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HIF1A—kidney cancer	3.66e-05	0.000346	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TSC2—kidney cancer	3.65e-05	0.000345	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CRABP1—kidney cancer	3.64e-05	0.000344	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—RAF1—kidney cancer	3.56e-05	0.000336	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—IL2—kidney cancer	3.51e-05	0.000332	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KDR—kidney cancer	3.5e-05	0.000331	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF2—kidney cancer	3.39e-05	0.00032	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ITPR2—kidney cancer	3.38e-05	0.000319	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN2B—kidney cancer	3.37e-05	0.000319	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF1R—kidney cancer	3.28e-05	0.00031	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APC—kidney cancer	3.22e-05	0.000305	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KIT—kidney cancer	3.22e-05	0.000305	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL2—kidney cancer	3.19e-05	0.000301	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—RAF1—kidney cancer	3.16e-05	0.000298	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—IL2—kidney cancer	3.12e-05	0.000295	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.12e-05	0.000295	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—MAPK3—kidney cancer	3.09e-05	0.000292	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ACHE—kidney cancer	3.08e-05	0.000291	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTT1—kidney cancer	3.08e-05	0.000291	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—POMC—kidney cancer	3.07e-05	0.00029	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HIF1A—kidney cancer	3.04e-05	0.000287	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—BRAF—kidney cancer	3.03e-05	0.000286	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TSC2—kidney cancer	3.03e-05	0.000286	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTGS2—kidney cancer	3e-05	0.000284	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—MAPK1—kidney cancer	2.94e-05	0.000278	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SCARB1—kidney cancer	2.92e-05	0.000276	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KDR—kidney cancer	2.9e-05	0.000275	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS1—kidney cancer	2.89e-05	0.000273	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PSMD7—kidney cancer	2.83e-05	0.000268	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL2—kidney cancer	2.83e-05	0.000268	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CA—kidney cancer	2.81e-05	0.000265	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—KRAS—kidney cancer	2.77e-05	0.000262	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HIF1A—kidney cancer	2.7e-05	0.000255	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TSC2—kidney cancer	2.69e-05	0.000254	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—BCHE—kidney cancer	2.69e-05	0.000254	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KIT—kidney cancer	2.68e-05	0.000253	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APC—kidney cancer	2.68e-05	0.000253	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC5A5—kidney cancer	2.65e-05	0.000251	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTEN—kidney cancer	2.62e-05	0.000247	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KDR—kidney cancer	2.58e-05	0.000244	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MAPK3—kidney cancer	2.56e-05	0.000242	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC2A1—kidney cancer	2.56e-05	0.000242	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CA—kidney cancer	2.55e-05	0.000241	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—POMC—kidney cancer	2.55e-05	0.000241	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RAF1—kidney cancer	2.53e-05	0.000239	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RELA—kidney cancer	2.52e-05	0.000238	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—BRAF—kidney cancer	2.52e-05	0.000238	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ERBB2—kidney cancer	2.5e-05	0.000237	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.49e-05	0.000235	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MTOR—kidney cancer	2.47e-05	0.000233	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MAPK1—kidney cancer	2.44e-05	0.00023	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APC—kidney cancer	2.38e-05	0.000225	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KIT—kidney cancer	2.38e-05	0.000225	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CA—kidney cancer	2.33e-05	0.00022	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CDKN1B—kidney cancer	2.32e-05	0.000219	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—KRAS—kidney cancer	2.3e-05	0.000218	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MAPK3—kidney cancer	2.28e-05	0.000215	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL2—kidney cancer	2.27e-05	0.000214	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—POMC—kidney cancer	2.26e-05	0.000214	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—BRAF—kidney cancer	2.23e-05	0.000211	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCND1—kidney cancer	2.21e-05	0.000209	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—JUN—kidney cancer	2.21e-05	0.000209	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CTNNB1—kidney cancer	2.19e-05	0.000207	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.17e-05	0.000205	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MAPK1—kidney cancer	2.17e-05	0.000205	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTP1—kidney cancer	2.14e-05	0.000202	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTEN—kidney cancer	2.13e-05	0.000202	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CA—kidney cancer	2.12e-05	0.0002	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RAF1—kidney cancer	2.1e-05	0.000198	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RELA—kidney cancer	2.09e-05	0.000198	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ERBB2—kidney cancer	2.08e-05	0.000196	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	2.07e-05	0.000196	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MTOR—kidney cancer	2.05e-05	0.000194	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	2.05e-05	0.000193	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCB1—kidney cancer	2.02e-05	0.000191	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTM1—kidney cancer	1.96e-05	0.000186	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—VEGFA—kidney cancer	1.93e-05	0.000182	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN1B—kidney cancer	1.92e-05	0.000182	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL2—kidney cancer	1.88e-05	0.000178	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	1.88e-05	0.000178	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RAF1—kidney cancer	1.87e-05	0.000176	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.86e-05	0.000176	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RELA—kidney cancer	1.86e-05	0.000176	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CA—kidney cancer	1.85e-05	0.000175	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	1.85e-05	0.000174	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCND1—kidney cancer	1.84e-05	0.000173	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—JUN—kidney cancer	1.83e-05	0.000173	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK3—kidney cancer	1.82e-05	0.000172	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MTOR—kidney cancer	1.82e-05	0.000172	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	1.82e-05	0.000172	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MYC—kidney cancer	1.77e-05	0.000168	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTEN—kidney cancer	1.77e-05	0.000167	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK1—kidney cancer	1.74e-05	0.000164	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	1.71e-05	0.000162	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL2—kidney cancer	1.67e-05	0.000158	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KRAS—kidney cancer	1.64e-05	0.000155	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCND1—kidney cancer	1.63e-05	0.000154	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—JUN—kidney cancer	1.63e-05	0.000154	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	1.61e-05	0.000153	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	1.6e-05	0.000151	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTEN—kidney cancer	1.57e-05	0.000149	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.53e-05	0.000145	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	1.51e-05	0.000143	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CA—kidney cancer	1.51e-05	0.000142	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MYC—kidney cancer	1.47e-05	0.000139	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TP53—kidney cancer	1.46e-05	0.000138	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	1.44e-05	0.000136	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	1.42e-05	0.000134	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—POMC—kidney cancer	1.39e-05	0.000131	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KRAS—kidney cancer	1.36e-05	0.000129	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	1.34e-05	0.000127	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MYC—kidney cancer	1.31e-05	0.000124	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	1.28e-05	0.000121	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	1.25e-05	0.000118	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TP53—kidney cancer	1.21e-05	0.000114	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KRAS—kidney cancer	1.21e-05	0.000114	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	1.11e-05	0.000105	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS2—kidney cancer	1.11e-05	0.000105	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TP53—kidney cancer	1.07e-05	0.000102	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTEN—kidney cancer	9.65e-06	9.12e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CA—kidney cancer	6.81e-06	6.44e-05	CbGpPWpGaD
